1
Clinical Trials associated with KSD-201 / Not yet recruitingEarly Phase 1 A Single-arm, Open-label, Single-center, Multiple-dose Early Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of KSD-201 in Patients with Advanced Clear Cell Renal Cell Carcinoma
The main purpse of this study is to evaluate the safety and tolerability of KSD-101 in patients with advanced clear cell renal cell carcinoma, to evaluate the initial clinical outcomes , immune response, and to evaluate the impact of KSD-201 on the quality of life in patients with advanced clear cell renal cell carcinoma.
100 Clinical Results associated with KSD-201
100 Translational Medicine associated with KSD-201
100 Patents (Medical) associated with KSD-201
100 Deals associated with KSD-201